Victor Tong Jr. is a Managing Director at Decheng Capital, focusing on biotech and medical technology investments in the US and China. He has held board positions at several companies and previously worked at Bay City Capital and Morgan Stanley.
At firms with a similar stage, sector and check size.

One email when Victor's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckVictor Tong Jr. is a Managing Director at Decheng Capital, focusing on biotech and medical technology investments in the US and China. He has held board positions at several companies and previously worked at Bay City Capital and Morgan Stanley.
Decheng Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Decheng Capital backed works best.
member of the healthcare investment banking division at Morgan Stanley; Principal at Bay City Capital.
Last updated 2026-10-15. Is this you? Ask for a correction.